Sareum Holdings Plc (LON:SAR)

Sareum Holdings Plc (LON:SAR)

Share Price
0.58 p
0 (0.00 %)
Market Cap
£16.54 m
Proactive Investors - Run By Investors For Investors

Sareum Holdings Plc

Sareum discovers and develops innovative drug candidates aimed at cancers and autoimmune diseases. Our drug development programmes aim to improve outcomes for patients with serious medical conditions and where current therapies are inadequate.

Market: AIM:SAR
52-week High/Low: 1.05p / 0.45p
Sector: Pharma & Biotech
Market Cap: 16.54M
col 3
col 4
col 5
col 6

Big Picture – A Deep Dive Examination of the Sareum Holdings Plc

Sareum Holdings Plc Timeline

"The data generated from these experiments are consistent with recent findings from our research and demonstrate that a potent and selective Chk1 inhibitor such as SRA737 can effectively synergize with sub-therapeutic doses of gemcitabine to induce replication catastrophe and tumour cell death”

© Proactive Investors 2019

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use